BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 21095542)

  • 1. Diabetic gastroparesis and its impact on glycemia.
    Chang J; Rayner CK; Jones KL; Horowitz M
    Endocrinol Metab Clin North Am; 2010 Dec; 39(4):745-62. PubMed ID: 21095542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose control is not improved by accelerating gastric emptying in patients with type 1 diabetes mellitus and gastroparesis. a pilot study with cisapride as a model drug.
    Lehmann R; Honegger RA; Feinle C; Fried M; Spinas GA; Schwizer W
    Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):255-61. PubMed ID: 12951630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of gastric emptying in diabetes.
    Phillips LK; Rayner CK; Jones KL; Horowitz M
    J Diabetes Complications; 2014; 28(6):894-903. PubMed ID: 25047170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic gastroparesis-backwards and forwards.
    Chang J; Rayner CK; Jones KL; Horowitz M
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():46-57. PubMed ID: 21199514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the motilin agonist KC 11458 on gastric emptying in diabetic gastroparesis.
    Russo A; Stevens JE; Giles N; Krause G; O'Donovan DG; Horowitz M; Jones KL
    Aliment Pharmacol Ther; 2004 Aug; 20(3):333-8. PubMed ID: 15274670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal hormonal dysfunction in gastroparesis and functional dyspepsia.
    Khoo J; Rayner CK; Feinle-Bisset C; Jones KL; Horowitz M
    Neurogastroenterol Motil; 2010 Dec; 22(12):1270-8. PubMed ID: 20939851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gastric emptying and diabetic instability].
    Valensi P; Miossec P; Attali JR
    Journ Annu Diabetol Hotel Dieu; 1995; ():257-70. PubMed ID: 7602886
    [No Abstract]   [Full Text] [Related]  

  • 8. Implication of neurohormonal-coupled mechanisms of gastric emptying and pancreatic secretory function in diabetic gastroparesis.
    Mussa BM; Sood S; Verberne AJ
    World J Gastroenterol; 2018 Sep; 24(34):3821-3833. PubMed ID: 30228777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of mitemcinal (GM-611), an orally active erythromycin-derived prokinetic agent, on delayed gastric emptying and postprandial glucose in a new minipig model of diabetes.
    Ozaki K; Monnai M; Onoma M; Muramatsu H; Yogo K; Watanabe T; Oda Y; Katagiri K; Arakawa H; Itoh Z; Omura S; Takanashi H
    J Diabetes Complications; 2008; 22(5):339-47. PubMed ID: 18413164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric emptying in diabetes.
    Kong MF; Macdonald IA; Tattersall RB
    Diabet Med; 1996 Feb; 13(2):112-9. PubMed ID: 8641114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in diabetic gastroparesis.
    Camilleri M
    Rev Gastroenterol Disord; 2002; 2(2):47-56. PubMed ID: 12122960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Early diagnosis of diabetic gastroparesis].
    Renner F; Mayr H
    Wien Klin Wochenschr; 1995; 107(7):225-30. PubMed ID: 7754616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Continuous glucose monitoring in type 2 diabetes with gastroparesis].
    Zeng WH; He XW; Shen J; Gu W
    Zhonghua Nei Ke Za Zhi; 2008 May; 47(5):397-400. PubMed ID: 18953950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutrition therapy for diabetic gastroparesis.
    Gentilcore D; O'Donovan D; Jones KL; Horowitz M
    Curr Diab Rep; 2003 Oct; 3(5):418-26. PubMed ID: 12975033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic Gastroparesis and Glycaemic Control.
    Jalleh R; Marathe CS; Rayner CK; Jones KL; Horowitz M
    Curr Diab Rep; 2019 Dec; 19(12):153. PubMed ID: 31792708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of gastric emptying and motility in diabetic gastroparesis with magnetic resonance imaging: effects of cisapride.
    Borovicka J; Lehmann R; Kunz P; Fraser R; Kreiss C; Crelier G; Boesiger P; Spinas GA; Fried M; Schwizer W
    Am J Gastroenterol; 1999 Oct; 94(10):2866-73. PubMed ID: 10520835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastroparesis: prevalence, clinical significance and treatment.
    Horowitz M; Su YC; Rayner CK; Jones KL
    Can J Gastroenterol; 2001 Dec; 15(12):805-13. PubMed ID: 11773947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitemcinal (GM-611), an orally active motilin receptor agonist, improves delayed gastric emptying in a canine model of diabetic gastroparesis.
    Onoma M; Ozaki K; Yogo K; Monnai M; Muramatsu H; Kamei K; Kawabe Y; Hayashi S; Shiga T; Matsuo S; Suzuki M; Itoh Z; Omura S; Takanashi H
    Clin Exp Pharmacol Physiol; 2008 Jul; 35(7):788-96. PubMed ID: 18346169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intravenous administration of EM523L on gastric emptying and plasma glucose levels after a meal in patients with diabetic gastroparesis: a pilot study.
    Nakamura T; Ishii M; Arai Y; Tandoh Y; Terada A; Takebe K
    Clin Ther; 1994; 16(6):989-99. PubMed ID: 7697695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced gastric emptying and mesenteric blood flow in IDDM with cardiac autonomic neuropathy.
    Weck M; Ott P; Matthies K
    Acta Med Austriaca; 1997; 24(5):180-4. PubMed ID: 9428944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.